Abstract 211
Diagnostic histology
N (% of cohort)
N (%) developing AC
N with intermediate histology
CLO-
137 (30.0%)
5 (3.6%)
2
CLOim
256 (54.1%)
12 (4.7%)
3
LGD
76 (16.1%)
4 (5.3%)
1
HGD
4 (0.8%)
2 (50.0%)
–